FDA Eyes New Administration Method For Monkeypox Vax To Boost Supply

By Jessica Karins / August 4, 2022 at 6:30 PM
FDA is mulling a new administration method for the two-dose Jynneos monkeypox vaccine that could substantially increase vaccine supply in the United States, FDA Commissioner Robert Califf says, coming as HHS declares a public health emergency in response to the monkeypox outbreak. The new administration method would allow for a smaller dose of Jynneos -- about one-fifth of the current dosing size -- to be injected intradermally (between the skin) instead of subcutaneously (underneath the skin). About 6,600 monkeypox cases...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.